FDA applicant

Syncor Pharmaceuticals, Inc.

Golden, CO4 decisions1999–20000 recalls

FDA records 4 decisions for Syncor Pharmaceuticals, Inc. (Golden, CO) from 1999 to 2000: 4 510(k) clearances. All are in product code KXK (Source, Brachytherapy, Radionuclide). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, radiology panel, where it files most

How often FDA has decided Syncor Pharmaceuticals, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Syncor Pharmaceuticals, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Syncor Pharmaceuticals, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Syncor Pharmaceuticals, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Syncor”

FDA records each applicant name separately; these may or may not be the same firm.

Syncor Intl. Corp. 31 Syncor International, Inc. 2 Syncor Radiation Management 1

Syncor Pharmaceuticals, Inc.

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Syncor”